Edward M. Copeland, III, MD

Articles by Edward M. Copeland, III, MD

Squamous Cell Carcinoma of the Anal Margin

ByWilliam M. Mendenhall, MD,Robert A. Zlotecki, MD, PhDand Jean-Nicolas Vauthey, MD,Edward M. Copeland, III, MD

November 1st 1996

Based on our experience and a review of the literature, we conclude that superficial, well- to moderately differentiated T1 cancers of the anal margin may be successfully treated with radiotherapy alone or local

Latest Updated Articles

Squamous Cell Carcinoma of the Anal Margin
November 1st 1996

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)